"When you or a loved one gets a cancer diagnosis, life can suddenly feel overwhelming. At the Providence Cancer Center, our team provides all the care, support and resources you and your family need – from treatment to survivorship – at one convenient location. We help you navigate your cancer journey every step of the way. As Alaska’s only full-service cancer center, we provide the most advanced diagnosis and treatment therapies, including clinical trials. At the same time, we surround you and your family in a warm and welcoming environment, right here at home. Your cancer care team answers your questions, helps you understand your treatment options and works with you to create a personalized care plan for your body, mind and spirit."

During the past decade, Providence Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 21 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 19 trials, followed by "Radiation Therapy Oncology Group" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "AstraZeneca" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "Eastern Cooperative Oncology Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Providence Cancer Center" are "Breast Cancer" (14 trials), "Prostate Cancer" (6 trials), "Lung Cancer" (5 trials), "Head and Neck Cancer" (4 trials) and "Metastatic Cancer" (4 trials). Many other conditions were trialed in "Providence Cancer Center" in a lesser frequency.

Most popular intervention types in "Providence Cancer Center" are "Drug" (36 trials), "Radiation" (17 trials), "Biological" (12 trials), "Procedure" (11 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (7 trials), "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (5 trials), "cetuximab" (4 trials) and "cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Providence Cancer Center" are 30 trials for "All" genders, 11 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Cancer Center". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Providence Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Cancer Center, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".